Intraarterial Treatment for Acute Ischemic Stroke due to Dissection: Retrospective Series of 24 Cases (P4.382)

Conclusions: Despite the additional intravascular risk, these results suggest the utility of IAT in patients with dissection.Disclosure: Dr. Jensen has nothing to disclose. Dr. Salottolo has nothing to disclose. Dr. McCarthy has nothing to disclose. Dr. Frei has received personal compensation for activities with Microvention, Covidien, Stryker, Siemens, and Penumbra as a consultant. Dr. Loy has nothing to disclose. Dr. Wagner has received personal compensation for activities with Genentech, Inc., as a speakers bureau member. Dr. Whaley has received personal compensation for activities with Clinical Data Management/Neurobase and Genentech. Dr. Bar-Or has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Non-Atherosclerotic Arteriopathies Source Type: research